Media

Keep up to date with all the latest news and updates from Virax Biolabs.

April 16, 2024

Virax Biolabs to Participate at ESCMID Global 2024

April 10, 2024

Post-Viral Syndromes and the Utility of T cell Diagnostics

January 8, 2024

James Foster CEO & Nigel McCracken COO – Virax Biolabs (with Don Davis PhD)

January 4, 2024

Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study

December 27, 2023

Identifying Post-Viral Syndromes Such as Long COVID

by John Parkinson

December 21, 2023

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

December 18, 2023

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

November 22, 2023

Dr. Nigel McCracken, Ph.D. – Chief Operating Officer, Virax Biolabs

November 21, 2023

16 Clinical Laboratory Predictions for 2024 (featuring James Foster)

October 4, 2023

“Regulatory reforms and incentives implemented by Middle Eastern countries have simplified market entry for life sciences companies” (featuring James Foster)

By Ayesha Siddiqui

October 2, 2023

Could a Predictive Test Fuel a Diagnostic Revolution? (featuring James Foster)

September 18, 2023

7 Reasons to Join ViraxImmune™’s T Cell Test Early Access Program

This week, we were excited to launch ViraxImmune™’s Research Use Only (RUO) Early Access Program. This program is designed to provide a new research tool and community for those committed